News

Revvity serves the pharmaceutical and biotech industries, diagnostic labs, academia. and governments in more than 160 ...
Immunai will generate a publicly accessible multi-omic dataset for a Parker Institute cohort of over 1,000 cancer patients.
Researchers show that glycoRNAs, uncovered by the lab of Nobel Laureate, Carolyn Bertozzi, can be used to fight cancer.
"Manufacturing these cutting-edge products inherently requires a workforce with enhanced knowledge and skills." ...
The scientists used a combination of short- and long-read sequencing data to assemble and analyze genomes from 28 members of the same family.
Researchers say study underscores how psychedelics may help dial down inflammation and reset brain-immune interactions.
The team tested the impact on eight novel helper plasmids with different deletions in the E2 and E4 genes on four rAAV serotypes. They discovered that some deletions affected productivity, reducing ...
Revvity and Watchmaker Genomics are working to bring more flexible and scalable NGS solutions to researchers worldwide.
One assay applies to bioprocesses that use the HEK293 human embryonic kidney cell line, often used in gene therapy development.
Researchers have developed a machine learning model that predicts Cas9 proteins that can be tailored with designer properties for therapeutic use.
Start listening today! The findings showed that dopamine signals in the two parts of the brain rise and fall in complex ...
The agreement allows EditCo to integrate Promega's HiBiT, HaloTag, and NanoLuc protein tagging tech with its knock-in gene ...